Clinical Trials Logo
  1. Home
  2. Venous Insufficiency
  3. NCT02929056

Amniotic Membrane Allograft Application in the Management of Venous Leg Ulcerations — AmnioExCel  

Venous Insufficiency Clinical Trial

Official title:
A Prospective Randomized Comparative Parallel Study of Amniotic Membrane in the Management of Venous Leg Ulcerations

Clinical Trial Summary

The purpose of this study is to evaluate and compare healing characteristics, reduction in the size of the wound and to measure complete healing of the wound following the application of a biologic product dressing instead of the alginate dressing along with standard debridement and compression therapy versus the standard of care treatment for VLUs. The biologic product that will be used in this study is called AmnioExCel™.

Clinical Trial Description

Approximately 40 participants will be enrolled in this study at the Greenville Health System. Participation is anticipated to last up to 15 weeks and will include a two week screening period, randomization (Visit 1) and office visits at the study doctor's office once every week for up to 12 weeks (Visit 2 - Visit 12). All participants will receive the standard of care wound treatment during the 2 week screening period. The treatment plan outlined in treatment group 1 or treatment group 2 will be followed after randomization. Participants will be randomly assigned (like flipping a coin) into one of two treatment groups. There is an equal chance to be enrolled into either of the two treatment groups. Neither the participant nor the study doctor can control the group assignment. Treatment Group 1: participants will receive the standard of care treatment including the use of a multi-layer compression wrap for their VLU. Treatment Group 2: participants will receive the application of the biologic product AmnioExCel™ dressing instead of the application of an alginate dressing in addition to standard debridement and the use of a multi-layer compression wrap for their VLU. If participants have more than one VLU, only one will be enrolled in the study and will receive the application of the AmnioExCel™ dressing. The remaining VLUs will receive the application of the alginate dressing. AmnioExCel™ is a human cellular and tissue based product that is registered with the United States Food and Drug Administration (FDA). It is intended for use as a wound covering and is made of a dehydrated human amniotic membrane (innermost layer of the placenta) that was obtained from donated human placenta. The use of AmnioExCel™ specifically for this study is not considered as standard of care. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02929056
Study type Interventional
Source Prisma Health-Upstate
Contact
Status Terminated
Phase Phase 4
Start date February 15, 2017
Completion date October 29, 2019
View Details
See also
  Status Clinical Trial Phase
Completed NCT05507346 - A Clinical Study to Evaluate the Effectiveness of a Novel Portable Non-Pneumatic Active Compression Device vs. an Advanced Pneumatic Compression Device for Treating Lower Extremity Lymphedema N/A
Completed NCT04469361 - The Effect of Training on Hemodynamic Factors in Ballet Dancer
Recruiting NCT05633277 - Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections N/A
Completed NCT03283800 - Copper Impact on Venous Insufficiency and Lipodermatosclerosis N/A
Terminated NCT03311269 - A Study Evaluating ClariVein With a Sclerosing Agent for the Treatment of Venous Insufficiency Phase 2
Withdrawn NCT01680809 - Compliance of Compression Therapy in Healed Venous Ulcerations N/A
Completed NCT00617825 - Feasibility Study of Cryotherapy for Chronic Venous Disorders N/A
Active, not recruiting NCT00270972 - The Evaluation of OrCel for the Treatment of Venous Ulcers N/A
Completed NCT01701661 - Compression Therapy Versus Surgery in the Treatment of Superficial Venous Reflux N/A
Active, not recruiting NCT06369207 - Investigation of the Transmission Pathways of Reflux in Patients With Chronic Venous Insufficiency
Completed NCT04461132 - The Effect of Manual Lymphatic Drainage N/A
Recruiting NCT04546750 - Prospective Cohort Study for Varicose Veins Incidence and Natural Course
Not yet recruiting NCT03543007 - Evaluating the Safety and Efficacy of GrafixPL™PRIME for the Treatment of Chronic Venous Leg Ulcers N/A
Active, not recruiting NCT02397226 - Lower Limb Venous Insufficiency and the Effect of Radiofrequency Treatment Versus Open Surgery N/A
Not yet recruiting NCT01110512 - Comparative Efficacy of Two Preparations of the Association Diosmin (450 mg) + Hesperidin (50 mg) in the Treatment of Chronic Venous Insufficiency (CVI) Phase 3
Completed NCT01298908 - Comparison of Treatments in Venous Insufficiency N/A
Completed NCT00565604 - Safety and Efficacy of Endovenous Laser Ablation for the Resolution of Incompetent Perforator Veins N/A
Active, not recruiting NCT00841178 - Endovenous Laser Therapy (EVLT) for Sapheno-Popliteal Incompetence and Short Saphenous Vein (SSV) Reflux: A RCT N/A
Not yet recruiting NCT03652025 - The Effectiveness of Trans-catheter Foam Sclerotherapy of Pelvic and Atypical Lower Limb Varicosities N/A
Completed NCT03755180 - Exercise Training in Venous Insufficiency N/A